Our Services
Medical Information
Helpful Resources
Published on: 4/24/2026
Red light therapy delivers targeted red and near-infrared wavelengths that stimulate cellular activity, enhance mitochondrial energy production, and support neurotransmitter balance. For people with seasonal affective disorder (SAD), this may help ease winter low mood and boost daytime energy levels.
Key considerations include choosing the right device, timing sessions properly, following safety precautions, and knowing when to consult a professional—see below for full details.
Because low mood, fatigue, and seasonal shifts can overlap with other conditions, it's smart to understand what's actually driving your symptoms before choosing a treatment path. Take a free, instant, online symptom check to clarify what may be going on and confidently plan your next steps.
Reviewed for medical accuracy: 07/10/2026
As daylight hours shrink, many people notice a dip in mood, energy and motivation. Known as seasonal affective disorder (SAD), this phenomenon can range from mild "winter blues" to debilitating depression. While traditional light boxes and psychotherapy are common treatments, recent research highlights red light therapy (RLT) as a promising complementary approach to lift mood and boost energy. Here's what you need to know.
Red light therapy (also called low-level light therapy or photobiomodulation) uses specific wavelengths of red and near-infrared (NIR) light—typically 630–850 nm—to gently stimulate cells. It's non-invasive, painless and widely used for:
Emerging evidence suggests RLT may also influence brain chemistry, helping alleviate symptoms of seasonal depression and increasing daytime energy.
Seasonal affective disorder often starts in late fall, peaks in mid-winter and fades by spring. Key symptoms include:
SAD is thought to stem from reduced sunlight exposure, which disrupts:
Traditional light therapy uses bright broad-spectrum bulbs (10,000 lux) to mimic natural sunlight. By comparison, RLT devices emit lower overall brightness but target cellular photoacceptors (mitochondrial chromophores), potentially offering unique benefits.
Mitochondrial Boost
Increased Neurotransmitter Balance
Reduced Inflammation
Improved Blood Flow
While research on RLT for SAD is still growing, early studies and trials provide encouraging data:
Choose the Right Device
Set a Routine
Protect Your Eyes
Combine with Lifestyle Measures
Red light therapy is generally safe, but keep these points in mind:
If you experience any of the following, speak to a healthcare provider promptly:
If you're experiencing concerning symptoms and need help understanding what might be causing them, use Ubie's free AI Symptom Checker to receive personalized insights and learn about your next steps.
Red light therapy offers a promising, low-risk way to enhance mood and energy levels during the darker months. While it shouldn't replace professional care for severe depression, integrating RLT into a holistic winter wellness plan can be a game-changer for many—helping you rise above the winter blues with renewed vitality.
If you experience life-threatening or serious symptoms, please speak to a doctor immediately.
(References)
* Cassano, P., Marook, A., Hamblin, M. R., Smith, D. F., Nyer, M. L., Ziemianowicz, D., Fava, M., Wong, M. L., Papakostas, G. I., Nierenberg, A. A., Dougherty, D. D., & Iosifescu, D. V. (2021). Transcranial photobiomodulation for depression: a comprehensive review of clinical data. *Annals of Translational Medicine*, *9*(24), 1797. 10.21037/atm-2020-sad-03
* Hamblin, M. R. (2016). Low-level light therapy for mood disorders: A systematic review. *BBA Clinical*, *6*, 179–186. 10.1016/j.bbacli.2016.10.001
* Schiffer, F., Johnston, A. L., Ravichandran, C., Polcari, A., Webb, R. H., & Teicher, M. H. (2014). Randomized, sham-controlled trial of transcranial near-infrared light therapy for depression. *Behavioral and Brain Functions*, *10*(1), 16. 10.1186/1744-9081-10-16
* Zomorrodi, R., Herrmann, N., Almeida, A., Das, B., Smith, S. M., Rajji, T. K., Husain, M. I., & Mulsant, B. H. (2019). Transcranial Photobiomodulation for Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. *Journal of Affective Disorders*, *247*, 34–42. 10.1016/j.jad.2019.01.006
* Vizioli, N. M., Khoury, B., Canas, R., & Cassano, P. (2020). Effects of transcranial photobiomodulation on cognitive function and mood: A systematic review of current evidence. *Journal of Affective Disorders*, *273*, 1–13. 10.1016/j.jad.2020.03.111
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.